NASDAQ:GENE • US37185R4065
Past quarterly earnings results for Genetic Technologies Ltd (GENE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2024 | - | - | 3.706M | - | -18.23% | |||
| Q2 2024 | - | - | 3.959M | - | -4.70% | |||
| Q4 2023 | - | - | 4.532M | - | -4.46% | |||
| Q2 2023 | - | - | 4.154M | - | 102.53% | |||
| Q4 2022 | - | - | 4.744M | - | 4,456.09% | |||
| Q2 2022 | - | - | 2.051M | - | 12,375.79% | |||
| Q4 2021 | - | - | 104.12K | - | 1,021.98% | |||
| Q2 2021 | - | - | 16.44K | - | 2,686.44% | |||
| Q4 2020 | - | - | 9.28K | - | - | |||
| Q2 2020 | - | - | 590 | - | - |
Notes
Genetic Technologies Ltd (GENE) last reported earnings on 8/29/2024.
Genetic Technologies Ltd (GENE) missed EPS estimates and missed revenue estimates in the most recent quarter.